Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multiple sclerosis-quenching the flames of inflammation.
Chataway J, Miller DH. Chataway J, et al. Among authors: miller dh. Lancet. 2011 Nov 19;378(9805):1759-60. doi: 10.1016/S0140-6736(11)61133-1. Epub 2011 Oct 31. Lancet. 2011. PMID: 22047970 No abstract available.
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.
Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell AW, Du MQ, Luan SL, Altmann DR, Thompson AJ, Compston A, Scott MA, Miller DH, Chandran S. Connick P, et al. Among authors: miller dh. Lancet Neurol. 2012 Feb;11(2):150-6. doi: 10.1016/S1474-4422(11)70305-2. Epub 2012 Jan 10. Lancet Neurol. 2012. PMID: 22236384 Free PMC article. Clinical Trial.
Natalizumab therapy for multiple sclerosis.
Chataway J, Miller DH. Chataway J, et al. Among authors: miller dh. Neurotherapeutics. 2013 Jan;10(1):19-28. doi: 10.1007/s13311-012-0171-4. Neurotherapeutics. 2013. PMID: 23307290 Free PMC article. Review.
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial.
Raftopoulos R, Hickman SJ, Toosy A, Sharrack B, Mallik S, Paling D, Altmann DR, Yiannakas MC, Malladi P, Sheridan R, Sarrigiannis PG, Hoggard N, Koltzenburg M, Gandini Wheeler-Kingshott CA, Schmierer K, Giovannoni G, Miller DH, Kapoor R. Raftopoulos R, et al. Among authors: miller dh. Lancet Neurol. 2016 Mar;15(3):259-69. doi: 10.1016/S1474-4422(16)00004-1. Epub 2016 Jan 26. Lancet Neurol. 2016. PMID: 26822749 Clinical Trial.
Phenytoin for neuroprotection - Authors' reply.
Kapoor R, Raftopoulos R, Altmann DR, Miller DH, Hickman SJ. Kapoor R, et al. Among authors: miller dh. Lancet Neurol. 2016 Aug;15(9):902-903. doi: 10.1016/S1474-4422(16)30094-1. Lancet Neurol. 2016. PMID: 27478948 No abstract available.
1,170 results